Hypermarcas SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypermarcas SA with three other
pharmaceutical manufacturers in Latin America:
Genomma Lab Internacional Sab De Cv
sales of 11.04 billion Mexican Pesos [US$505.08 million]
of which 64%
(1.89 billion Brazilian Reals [US$592.55 million]
of which 84%
was Diagnostic Medicine), and
Diagnosticos Da America SA
(2.79 billion Brazilian Reals [US$873.81 million]
of which 100%
was servi os auxiliares).
Hypermarcas SA reported sales of 2.96 billion Brazilian Reals (US$924.54 million)
December of 2015.
decrease of 36.8%
versus 2014, when the company's sales were 4.68 billion Brazilian Reals.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Hypermarcas SA had sales
of 3.16 billion Brazilian Reals.